KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Acquisitions & Divestments: 2023-2025

Historic Change in Acquisitions & Divestments for Castle Biosciences (CSTL) over the last 3 years, with Sep 2025 value amounting to $54.9 million.

  • Castle Biosciences' Change in Acquisitions & Divestments rose 49.18% to $54.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.8 million, marking a year-over-year increase of 14.03%. This contributed to the annual value of $183.9 million for FY2024, which is 1.39% down from last year.
  • As of Q3 2025, Castle Biosciences' Change in Acquisitions & Divestments stood at $54.9 million, which was up 24.77% from $44.0 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Change in Acquisitions & Divestments peaked at $60.6 million during Q4 2024, and registered a low of $36.2 million during Q2 2024.
  • In the last 3 years, Castle Biosciences' Change in Acquisitions & Divestments had a median value of $45.0 million in 2023 and averaged $46.0 million.
  • Within the past 5 years, the most significant YoY rise in Castle Biosciences' Change in Acquisitions & Divestments was 49.18% (2025), while the steepest drop was 27.69% (2025).
  • Quarterly analysis of 3 years shows Castle Biosciences' Change in Acquisitions & Divestments stood at $48.5 million in 2023, then rose by 25.05% to $60.6 million in 2024, then surged by 49.18% to $54.9 million in 2025.
  • Its last three reported values are $54.9 million in Q3 2025, $44.0 million for Q2 2025, and $36.3 million during Q1 2025.